Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ICU Medical, Inc. (ICUI)
USD160.95
+7.46 (+4.86%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
951 Calle Amanecer 92673
San Clemente, CA, US
San Clemente, CA, US
CEO
Vivek Jain
Website
icumed.com
IPO
1992-03-31
CIK 883984 ISIN US44930G1076
Description
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD160.95
+7.46 (+4.86%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
298.5K
Beta
0.76
Float Shares
24.21M
Free Float %
96.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.38% | +2.85% | -0.80% | -12.21% | -10.40% | -12.61% | -13.62% | -37.88% | -34.66% | +24.22% | +2,603.90% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
160.95
Low
163.00
+1.3%
Consensus
163.50
+1.6%
Median
163.50
+1.6%
High
164.00
+1.9%
DCF (Levered)
212.04
+31.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
86% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
163.50
+1.6%
|
| Last Quarter | 4 |
171.25
+6.4%
|
| Last Year | 7 |
165.14
+2.6%
|
| All Time | 14 |
171.57
+6.6%
|
Quality scores
Altman Z-Score
2.06
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
2 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-6.4% Q1'26: -12.3% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+100.6% ★ Q1'26: +290.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+1.8% Q1'26: +5.2% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+4.9% Q1'26: +5.8% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+2.0% Q1'26: +2.3% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+2.1% Q1'26: +2.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×4.26× Q1'26: 4.15× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
302.20M
est: 258.85M (+16.7%)
|
316.87M
est: 286.94M (+10.4%)
|
313.72M
est: 307.75M (+1.9%)
|
309.26M
est: 250.58M (+23.4%)
|
341.67M
est: 337.84M (+1.1%)
|
379.37M
est: 378.14M (+0.3%)
|
1.29B
est: 1.25B (+3.3%)
|
1.40B
est: 1.32B (+6.4%)
|
1.27B
est: 1.19B (+6.7%)
|
1.27B
est: 1.20B (+5.7%)
|
1.32B
est: 1.26B (+4.2%)
|
2.28B
est: 2.24B (+1.8%)
|
2.26B
est: 2.30B (-2.0%)
|
2.38B
est: 2.32B (+2.8%)
|
2.23B
est: 2.21B (+1.1%)
|
2.17B
2.15B – 2.20B
-1.5% YoY
|
2.27B
2.23B – 2.30B
+4.4% YoY
|
2.41B
2.40B – 2.41B
+6.0% YoY
|
2.31B
2.28B – 2.34B
-4.0% YoY
|
2.36B
2.34B – 2.39B
+2.4% YoY
|
| EBITDA |
84.72M
est: 71.22M (+18.9%)
|
80.28M
est: 72.06M (+11.4%)
|
72.83M
est: 66.34M (+9.8%)
|
63.58M
est: 44.83M (+41.8%)
|
99.94M
est: 71.32M (+40.1%)
|
118.07M
est: 40.58M (+190.9%)
|
205.54M
est: 134.31M (+53.0%)
|
271.89M
est: 67.64M (+302.0%)
|
192.17M
est: 183.04M (+5.0%)
|
194.09M
est: 144.89M (+34.0%)
|
223.46M
est: 191.55M (+16.7%)
|
191.55M
est: 218.69M (-12.4%)
|
253.20M
est: 244.40M (+3.6%)
|
42.96M
est: 245.87M (-82.5%)
|
326.54M
est: 233.97M (+39.6%)
|
230.47M
228.36M – 233.64M
-1.5% YoY
|
240.61M
236.39M – 243.78M
+4.4% YoY
|
255.15M
254.29M – 256.00M
+6.0% YoY
|
244.92M
242.21M – 247.69M
-4.0% YoY
|
250.69M
247.92M – 253.53M
+2.4% YoY
|
| EBIT |
48.48M
est: 54.95M (-11.8%)
|
61.84M
est: 54.60M (+13.3%)
|
53.32M
est: 47.54M (+12.1%)
|
44.13M
est: 29.63M (+49.0%)
|
69.74M
est: 55.29M (+26.1%)
|
85.28M
est: 13.70M (+522.6%)
|
53.33M
est: 45.33M (+17.6%)
|
197.16M
est: 10.35M (+1,805.2%)
|
115.26M
est: 98.52M (+17.0%)
|
99.25M
est: 74.07M (+34.0%)
|
124.17M
est: 110.24M (+12.6%)
|
-43.60M
est: 24.43M (-278.5%)
|
24.43M
est: 69.92M (-65.1%)
|
40.53M
est: 70.34M (-42.4%)
|
108.55M
est: 66.93M (+62.2%)
|
65.93M
65.33M – 66.84M
-1.5% YoY
|
68.83M
67.62M – 69.74M
+4.4% YoY
|
72.99M
72.75M – 73.23M
+6.0% YoY
|
70.06M
69.29M – 70.86M
-4.0% YoY
|
71.72M
70.92M – 72.53M
+2.4% YoY
|
| Net Income |
44.67M
est: 37.67M (+18.6%)
|
41.28M
est: 36.73M (+12.4%)
|
40.42M
est: 36.47M (+10.8%)
|
26.34M
est: 19.82M (+32.9%)
|
44.99M
est: 35.84M (+25.5%)
|
63.08M
est: 118.09M (-46.6%)
|
68.64M
est: 112.25M (-38.8%)
|
28.79M
est: 16.07M (+79.1%)
|
101.04M
est: 91.54M (+10.4%)
|
86.87M
est: 64.38M (+34.9%)
|
103.14M
est: 92.31M (+11.7%)
|
-74.29M
est: -48.49M (-53.2%)
|
-29.66M
est: -72.81M (+59.3%)
|
-117.69M
est: 139.55M (-184.3%)
|
732.0K
est: 188.94M (-99.6%)
|
202.71M
199.69M – 205.73M
+7.3% YoY
|
230.65M
220.02M – 241.28M
+13.8% YoY
|
256.14M
235.28M – 276.99M
+11.1% YoY
|
261.49M
257.73M – 265.34M
+2.1% YoY
|
276.19M
272.21M – 280.25M
+5.6% YoY
|
| SGA |
85.29M
est: 69.24M (+23.2%)
|
84.60M
est: 75.66M (+11.8%)
|
90.38M
est: 83.85M (+7.8%)
|
88.94M
est: 67.05M (+32.6%)
|
83.22M
est: 69.53M (+19.7%)
|
89.43M
est: 95.05M (-5.9%)
|
303.95M
est: 314.58M (-3.4%)
|
328.15M
est: 244.72M (+34.1%)
|
276.98M
est: 250.91M (+10.4%)
|
283.95M
est: 213.05M (+33.3%)
|
302.58M
est: 271.08M (+11.6%)
|
608.35M
est: 498.60M (+22.0%)
|
606.69M
est: 605.45M (+0.2%)
|
638.76M
est: 609.10M (+4.9%)
|
625.21M
est: 579.62M (+7.9%)
|
570.94M
565.70M – 578.80M
-1.5% YoY
|
596.07M
585.61M – 603.91M
+4.4% YoY
|
632.08M
629.96M – 634.19M
+6.0% YoY
|
606.75M
600.04M – 613.61M
-4.0% YoY
|
621.04M
614.17M – 628.06M
+2.4% YoY
|
| EPS |
3.23
est: 1.87 (+72.7%)
|
2.90
est: 2.26 (+28.3%)
|
2.75
est: 2.36 (+16.5%)
|
1.72
est: 1.31 (+31.3%)
|
2.84
est: 3.78 (-24.8%)
|
3.90
est: 4.84 (-19.5%)
|
3.50
est: 4.60 (-24.0%)
|
1.33
est: 8.57 (-84.5%)
|
4.90
est: 7.86 (-37.6%)
|
4.16
est: 6.79 (-38.8%)
|
4.86
est: 7.21 (-32.6%)
|
-3.11
est: 6.50 (-147.8%)
|
-1.23
est: -2.92 (+57.9%)
|
-4.83
est: 5.61 (-186.1%)
|
0.03
est: 7.57 (-99.6%)
|
8.17
8.02 – 8.26
+7.9% YoY
|
9.30
8.83 – 9.69
+13.8% YoY
|
10.29
9.45 – 11.12
+10.6% YoY
|
10.50
10.35 – 10.65
+2.1% YoY
|
11.09
10.93 – 11.25
+5.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-27 | Keybanc | Overweight | Overweight | Maintain |
| 2026-04-17 | Piper Sandler | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
921.5K
OE per share TTM
0.03
Owner's Yield
0.03%
Maintenance CapEx ratio
112.00%
Maint CapEx / Avg PPE
30.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
89
Total invested
263.16M
Insider transactions (90d)
0
Beneficial owners (>5%)
32
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Clifford Teller | 5.00M | 100.00% | — | 1.50M | — | 1.50M | IN | Jersey Channel Islands | 2018-02-12 | ↗ |
| 2 | VANGUARD SPECIALIZED FUNDS - VANGUARD REIT INDEX FUND | 3.43M | 5.14% | 16.5K | — | 852.5K | 15.7K | IV | Pennsylvania | 2013-02-13 | ↗ |
| 3 | 85-4328500 | 2.43M | 10.10% | 901.6K | — | 2.43M | — | IA | Maryland | 2022-08-10 | ↗ |
| 4 | Wellington Group Holdings LLP | 2.37M | 9.87% | — | 1.92M | — | — | HC | Delaware | 2023-02-06 | ↗ |
| 5 | Wellington Investment Advisors Holdings LLP | 2.37M | 9.87% | — | 1.92M | — | — | HC | Delaware | 2023-02-06 | ↗ |
| 6 | Wellington Management Group LLP | 2.37M | 9.87% | — | 1.92M | — | — | HC | Massachusetts | 2023-02-06 | ↗ |
| 7 | EIN #00-0000000 | 2.29M | 10.80% | — | 2.29M | — | 2.29M | IA, HC | Jersey, Channel Islands | 2022-02-10 | ↗ |
| 8 | 061523639 | 1.83M | 12.97% | 77.3K | 1.15M | — | 1.83M | HC | Delaware | 2006-02-21 | ↗ |
| 9 | 135521910 | 1.83M | 12.97% | 77.3K | 1.15M | — | 1.83M | BD, IA | Delaware | 2006-02-21 | ↗ |
| 10 | (1) BlackRock, Inc. | 1.69M | 7.90% | 1.60M | — | 1.69M | — | HC | Delaware | 2022-02-01 | ↗ |
| 11 | Wellington Management Company LLP | 1.63M | 6.81% | — | 1.48M | — | — | IA | Delaware | 2023-02-06 | ↗ |
| 12 | only) | 1.52M | 11.00% | 1.52M | — | 1.52M | — | IA | Number | 2005-03-03 | ↗ |
| 13 | Fuller & Thaler Asset Management, Inc. | 1.47M | 6.10% | 1.44M | — | 1.47M | — | IA | — | 2024-02-13 | ↗ |
| 14 | 132667528 | 1.15M | 8.10% | — | 1.15M | — | 1.15M | BD, IA | New York | 2006-02-21 | ↗ |
| 15 | 134035886 | 1.15M | 6.90% | — | 1.15M | — | 1.15M | IV | Delaware | 2006-02-21 | ↗ |
| 16 | Abigail P. Johnson | 1.13M | 13.00% | — | — | 1.13M | — | IN | United States of America | 2002-02-14 | ↗ |
| 17 | FMR Corp. | 1.13M | 13.00% | 6.7K | — | 1.13M | — | HC | Commonwealth of Massachusetts | 2002-02-14 | ↗ |
| 18 | Columbia Wanger Asset Management, L.P. 36-3820584 | 901.5K | 6.60% | — | 901.5K | — | 901.5K | IA | Delaware | 2004-02-13 | ↗ |
| 19 | WAM Acquisition GP, Inc. | 901.5K | 6.60% | — | 901.5K | — | 901.5K | CO | Delaware | 2004-02-13 | ↗ |
| 20 | 26-0385758 | 812.8K | 5.05% | 722.2K | — | 762.2K | 50.6K | IA | Delaware | 2016-02-12 | ↗ |
| 21 | 04-2683227 | 785.3K | 5.47% | — | 552.6K | — | — | IA | Massachusetts | 2009-02-17 | ↗ |
| 22 | Eaton Vance Management | 725.0K | 5.30% | 725.0K | — | 725.0K | — | IA | WITH: | 2004-02-13 | ↗ |
| 23 | Rice Hall James & Associates, LLC | 519.8K | 3.83% | 452.5K | — | 519.8K | — | IA, OO | REPORTING PERSON WITH: | 2005-03-04 | ↗ |
| 24 | Zurich Scudder Investments, Inc. | 504.8K | 11.00% | 311.0K | 9.2K | 504.8K | — | IA | Delaware | 2002-02-01 | ↗ |
| 25 | Scudder Kemper Investments, Inc. | 492.8K | 11.00% | 288.0K | 6.6K | 492.8K | — | IA | Delaware | 2000-01-28 | ↗ |
| 26 | Edward C. Johnson 3d | 433.1K | 2.97% | — | — | 433.1K | — | IN | Delaware | 2013-06-10 | ↗ |
| 27 | 52-0556948 | 270.0K | 1.10% | 79.7K | — | 270.0K | — | IA | Maryland | 2022-08-10 | ↗ |
| 28 | 25-1894430 | 92.7K | 0.64% | — | — | — | — | IA | : | 2006-08-03 | ↗ |
| 29 | Neuberger Berman Inc. | 500.00 | 0.00% | — | — | — | 500.00 | HC | Delaware | 2008-07-10 | ↗ |
| 30 | 13-1957714 | — | 11.00% | — | — | — | — | BD, IA, PN | New York | 2009-02-10 | ↗ |
| 31 | Neuberger Berman Equity Funds | — | 0.00% | — | — | — | — | IV | Delaware | 2008-07-10 | ↗ |
| 32 | Neuberger Berman Management Inc. | — | 0.00% | — | — | — | — | IA | Delaware | 2008-07-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
89
-204 vs prev Q
New positions
10
Closed positions
212
Increased
36
Reduced
34
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 340.7K +340.7K (+100.0%) | 48.61B +48.6B (+100.0%) | 1.38% +1.380 pp | 6.59% +6.590 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 2 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 273.4K +273.4K (+100.0%) | 39.01B +39.0B (+100.0%) | 1.11% +1.108 pp | 0.06% +0.059 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 3 | BLACKROCK, INC. | 3.59M +66.6K (+1.9%) | 511.92M +89.5M (+21.2%) | 14.54% +0.246 pp | 0.01% +0.001 pp | USD181.21 -21.3% | 6 qtrs — |
| 4 | VANGUARD GROUP INC | 2.71M +89.8K (+3.4%) | 387.31M +72.4M (+23.0%) | 11.00% +0.346 pp | 0.01% +0.001 pp | USD143.06 -0.3% | 84 qtrs — |
| 5 | JANUS HENDERSON GROUP PLC | 2.58M +103.2K (+4.2%) | 367.63M +70.9M (+23.9%) | 10.44% +0.402 pp | 0.16% +0.029 pp | USD193.68 -26.3% | 35 qtrs — |
| 6 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.27M -119.4K (-8.6%) | 180.59M +14.4M (+8.7%) | 5.13% -0.493 pp | 0.61% +0.045 pp | USD129.72 +10.0% | 15 qtrs — |
| 7 | STATE STREET CORP | 942.7K +25.5K (+2.8%) | 134.49M +24.5M (+22.2%) | 3.82% +0.097 pp | 0.00% +0.001 pp | USD147.97 -3.6% | 51 qtrs — |
| 8 | DIMENSIONAL FUND ADVISORS LP | 920.8K +47.8K (+5.5%) | 131.37M +26.7M (+25.5%) | 3.73% +0.188 pp | 0.03% +0.005 pp | USD139.69 +2.1% | 51 qtrs — |
| 9 | SCHRODER INVESTMENT MANAGEMENT GROUP | 765.4K -31.3K (-3.9%) | 110.70M +17.5M (+18.7%) | 3.10% -0.132 pp | 0.08% +0.012 pp | USD140.88 +1.3% | 24 qtrs — |
| 10 | AMERIPRISE FINANCIAL INC | 661.4K -142.2K (-17.7%) | 94.36M -2.0M (-2.1%) | 2.68% -0.581 pp | 0.02% -0.001 pp | USD135.85 +5.0% | 55 qtrs — |
| 11 | RIVER ROAD ASSET MANAGEMENT, LLC | 650.9K -284.0 (0.0%) | 92.86M +14.7M (+18.9%) | 2.64% -0.006 pp | 1.02% +0.143 pp | USD134.34 +6.2% | 4 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 593.5K +157.0 (+0.0%) | 84.69M +13.5M (+19.0%) | 2.40% -0.003 pp | 0.01% +0.001 pp | USD143.55 -0.6% | 78 qtrs — |
| 13 | NEUBERGER BERMAN GROUP LLC | 563.8K -78.1K (-12.2%) | 80.44M +3.4M (+4.5%) | 2.28% -0.321 pp | 0.06% +0.004 pp | USD145.24 -1.8% | 37 qtrs — |
| 14 | JPMORGAN CHASE & CO | 529.1K -147.3K (-21.8%) | 75.49M -5.6M (-7.0%) | 2.14% -0.601 pp | 0.00% 0.000 pp | USD158.47 -10.0% | 51 qtrs — |
| 15 | MORGAN STANLEY | 518.6K -46.6K (-8.2%) | 73.99M +6.2M (+9.1%) | 2.10% -0.192 pp | 0.00% +0.000 pp | USD153.08 -6.8% | 51 qtrs — |
| 16 | NORGES BANK | 407.1K +407.1K (+100.0%) | 58.08M +58.1M (+100.0%) | 1.65% +1.649 pp | 0.01% +0.006 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 17 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 380.5K -52.3K (-12.1%) | 54.28M +2.4M (+4.6%) | 1.54% -0.215 pp | 0.37% +0.030 pp | USD119.89 +19.0% | 59 qtrs — |
| 18 | FMR LLC | 362.5K -2.8K (-0.8%) | 51.71M +7.9M (+18.0%) | 1.47% -0.014 pp | 0.00% +0.000 pp | USD149.95 -4.9% | 33 qtrs — |
| 19 | NORTHERN TRUST CORP | 338.8K -47.1K (-12.2%) | 48.34M +2.0M (+4.4%) | 1.37% -0.193 pp | 0.01% +0.000 pp | USD157.79 -9.6% | 51 qtrs — |
| 20 | POINT72 ASSET MANAGEMENT, L.P. | 337.7K +285.8K (+550.8%) | 48.19M +42.0M (+674.0%) | 1.37% +1.158 pp | 0.05% +0.044 pp | USD140.20 +1.8% | 9 qtrs — |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 309.6K +2.4K (+0.8%) | 44.17M +7.3M (+19.9%) | 1.25% +0.008 pp | 0.01% +0.001 pp | USD152.51 -6.5% | 99 qtrs — |
| 22 | THRIVENT FINANCIAL FOR LUTHERANS | 303.5K +285.6K (+1,604.0%) | 43.29M +41.2M (+1,926.9%) | 1.23% +1.157 pp | 0.08% +0.073 pp | USD142.29 +0.3% | 60 qtrs — |
| 23 | BANK OF AMERICA CORP /DE/ | 298.2K +48.6K (+19.5%) | 42.55M +12.6M (+42.1%) | 1.21% +0.195 pp | 0.00% +0.001 pp | USD148.12 -3.7% | 52 qtrs — |
| 24 | GOLDMAN SACHS GROUP INC | 284.6K +5.8K (+2.1%) | 40.60M +7.2M (+21.4%) | 1.15% +0.022 pp | 0.01% +0.001 pp | USD144.79 -1.5% | 73 qtrs — |
| 25 | QUANTINNO CAPITAL MANAGEMENT LP | 278.7K +26.3K (+10.4%) | 39.76M +9.5M (+31.3%) | 1.13% +0.105 pp | 0.08% -0.003 pp | USD126.26 +13.0% | 10 qtrs — |
| 26 | SEGALL BRYANT & HAMILL, LLC | 265.0K -15.5K (-5.5%) | 37.81M +4.2M (+12.3%) | 1.07% -0.065 pp | 0.51% +0.063 pp | USD175.60 -18.8% | 34 qtrs — |
| 27 | WELLINGTON MANAGEMENT GROUP LLP | 248.4K +10.6K (+4.5%) | 35.44M +6.9M (+24.2%) | 1.01% +0.041 pp | 0.01% +0.001 pp | USD162.38 -12.1% | 71 qtrs — |
| 28 | FEDERATED HERMES, INC. | 247.0K -43.3K (-14.9%) | 35.24M +420.1K (+1.2%) | 1.00% -0.177 pp | 0.06% -0.003 pp | USD141.48 +0.8% | 45 qtrs — |
| 29 | BROWN ADVISORY INC | 227.4K +227.4K (+100.0%) | 32.44M +32.4M (+100.0%) | 0.92% +0.921 pp | 0.05% +0.045 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 30 | CITADEL ADVISORS LLC | 210.9K +210.9K (+100.0%) | 30.09M +30.1M (+100.0%) | 0.85% +0.854 pp | 0.00% +0.005 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 31 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 210.8K -21.4K (-9.2%) | 30.07M +2.2M (+8.0%) | 0.85% -0.088 pp | 0.08% +0.012 pp | USD131.06 +8.9% | 3 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 181.5K -14.8K (-7.5%) | 25.90M +2.3M (+10.0%) | 0.74% -0.061 pp | 0.00% +0.000 pp | USD125.55 +13.6% | 66 qtrs — |
| 33 | VICTORY CAPITAL MANAGEMENT INC | 179.6K -32.9K (-15.5%) | 25.62M +126.9K (+0.5%) | 0.73% -0.135 pp | 0.01% 0.000 pp | USD119.17 +19.7% | 26 qtrs — |
| 34 | UBS GROUP AG | 179.6K -207.0K (-53.5%) | 25.62M -20.8M (-44.7%) | 0.73% -0.841 pp | 0.00% -0.003 pp | USD129.63 +10.1% | 45 qtrs — |
| 35 | RAYMOND JAMES FINANCIAL INC | 174.3K +34.0K (+24.2%) | 24.87M +8.0M (+47.7%) | 0.71% +0.137 pp | 0.01% +0.002 pp | USD141.03 +1.2% | 5 qtrs — |
| 36 | OBERWEIS ASSET MANAGEMENT INC/ | 168.0K +18.9K (+12.7%) | 23.97M +6.1M (+34.0%) | 0.68% +0.076 pp | 0.88% +0.192 pp | USD173.76 -17.9% | 6 qtrs — |
| 37 | WCM INVESTMENT MANAGEMENT, LLC | 165.2K -42.2K (-20.4%) | 23.90M -382.7K (-1.6%) | 0.67% -0.172 pp | 0.05% -0.001 pp | USD165.67 -13.9% | 19 qtrs — |
| 38 | WOODLINE PARTNERS LP | 164.3K +— (+0.0%) | 23.44M +3.7M (+18.9%) | 0.67% -0.001 pp | 0.09% -0.002 pp | USD119.48 +19.4% | 25 qtrs — |
| 39 | NITORUM CAPITAL, L.P. | 153.7K -29.5K (-16.1%) | 21.92M -45.9K (-0.2%) | 0.62% -0.121 pp | 4.85% +0.987 pp | USD133.43 +6.9% | 27 qtrs — |
| 40 | PRINCIPAL FINANCIAL GROUP INC | 140.1K +6.8K (+5.1%) | 19.99M +4.0M (+25.0%) | 0.57% +0.027 pp | 0.01% +0.002 pp | USD144.99 -1.6% | 81 qtrs — |
| 41 | KENNEDY CAPITAL MANAGEMENT LLC | 128.0K +742.0 (+0.6%) | 18.27M +3.0M (+19.6%) | 0.52% +0.002 pp | 0.39% +0.049 pp | USD125.08 +14.1% | 37 qtrs — |
| 42 | NUVEEN, LLC | 119.5K +6.9K (+6.1%) | 17.04M +3.5M (+26.2%) | 0.48% +0.027 pp | 0.00% +0.001 pp | USD132.72 +7.5% | 4 qtrs — |
| 43 | INVESCO LTD. | 100.5K -10.6K (-9.6%) | 14.34M +1.0M (+7.5%) | 0.41% -0.044 pp | 0.00% +0.000 pp | USD138.27 +3.2% | 57 qtrs — |
| 44 | UBS ASSET MANAGEMENT AMERICAS INC | 88.6K +10.6K (+13.5%) | 12.64M +3.3M (+35.0%) | 0.36% +0.042 pp | 0.00% +0.001 pp | USD152.02 -6.2% | 61 qtrs — |
| 45 | GLENMEDE TRUST CO NA | 88.3K +88.3K (+100.0%) | 12.60M +12.6M (+100.0%) | 0.36% +0.358 pp | 0.06% +0.060 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 46 | MILLENNIUM MANAGEMENT LLC | 87.1K -1.0M (-92.0%) | 12.43M -118.2M (-90.5%) | 0.35% -4.066 pp | 0.01% -0.051 pp | USD133.42 +6.9% | 13 qtrs — |
| 47 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 85.4K -10.9K (-11.3%) | 12.18M +635.5K (+5.5%) | 0.35% -0.045 pp | 0.04% -0.001 pp | USD122.84 +16.1% | 9 qtrs — |
| 48 | GRANITE INVESTMENT PARTNERS, LLC | 72.3K -4.8K (-6.3%) | 10.32M +1.1M (+11.5%) | 0.29% -0.020 pp | 0.61% +0.086 pp | USD124.32 +14.8% | 7 qtrs — |
| 49 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 70.0K +62.4K (+826.8%) | 9.99M +9.1M (+1,002.3%) | 0.28% +0.253 pp | 0.08% +0.069 pp | USD140.80 +1.3% | 13 qtrs — |
| 50 | GABELLI FUNDS LLC | 68.6K -10.4K (-13.2%) | 9.79M +310.3K (+3.3%) | 0.28% -0.043 pp | 0.07% +0.002 pp | USD169.72 -15.9% | 64 qtrs — |
| 51 | RHUMBLINE ADVISERS | 68.1K -1.0K (-1.5%) | 9.72M +1.4M (+17.1%) | 0.28% -0.005 pp | 0.01% +0.001 pp | USD156.74 -9.0% | 51 qtrs — |
| 52 | LEGAL & GENERAL GROUP PLC | 62.4K -2.8K (-4.2%) | 8.90M +1.1M (+13.9%) | 0.25% -0.012 pp | 0.00% +0.000 pp | USD154.10 -7.4% | 46 qtrs — |
| 53 | JANE STREET GROUP, LLC | 55.1K +42.4K (+335.0%) | 7.86M +6.3M (+417.3%) | 0.22% +0.172 pp | 0.00% +0.001 pp | USD139.48 +2.3% | 27 qtrs — |
| 54 | F/M INVESTMENTS LLC | 46.5K +11.6K (+33.3%) | 6.64M +2.4M (+58.5%) | 0.19% +0.047 pp | 0.25% +0.091 pp | USD122.85 +16.1% | 7 qtrs — |
| 55 | SWISS NATIONAL BANK | 46.3K +900.0 (+2.0%) | 6.61M +1.2M (+21.3%) | 0.19% +0.003 pp | 0.00% +0.001 pp | USD149.75 -4.7% | 51 qtrs — |
| 56 | PRUDENTIAL FINANCIAL INC | 40.3K -5.9K (-12.8%) | 5.74M +204.7K (+3.7%) | 0.16% -0.024 pp | 0.01% +0.000 pp | USD157.78 -9.6% | 85 qtrs — |
| 57 | COMERICA BANK | 39.7K +13.7K (+52.6%) | 5.66M +2.5M (+81.5%) | 0.16% +0.055 pp | 0.02% +0.011 pp | USD128.27 +11.2% | 10 qtrs — |
| 58 | BARCLAYS PLC | 37.7K -21.5K (-36.3%) | 5.38M -5.4M (-50.1%) | 0.15% -0.088 pp | 0.00% -0.002 pp | USD123.45 +15.6% | 38 qtrs — |
| 59 | KIRR MARBACH & CO LLC /IN/ | 37.3K +1.2K (+3.3%) | 5.32M +990.4K (+22.9%) | 0.15% +0.005 pp | 1.02% +0.235 pp | USD150.20 -5.0% | 26 qtrs — |
| 60 | RENAISSANCE TECHNOLOGIES LLC | 36.3K -33.1K (-47.7%) | 5.18M -3.1M (-37.8%) | 0.15% -0.135 pp | 0.01% -0.003 pp | USD132.83 +7.4% | 4 qtrs — |
| 61 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 35.6K +32.1K (+926.4%) | 5.07M +4.7M (+1,120.8%) | 0.14% +0.130 pp | 0.00% +0.003 pp | USD140.46 +1.6% | 2 qtrs — |
| 62 | SEI INVESTMENTS CO | 34.5K +193.0 (+0.6%) | 4.93M +807.5K (+19.6%) | 0.14% +0.001 pp | 0.00% +0.000 pp | USD144.27 -1.1% | 45 qtrs — |
| 63 | NORDEA INVESTMENT MANAGEMENT AB | 32.8K -4.4K (-11.8%) | 4.71M +387.3K (+9.0%) | 0.13% -0.018 pp | 0.00% +0.000 pp | USD138.15 +3.3% | 4 qtrs — |
| 64 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 30.4K -7.2K (-19.2%) | 4.33M -175.4K (-3.9%) | 0.12% -0.030 pp | 0.00% 0.000 pp | USD140.90 +1.3% | 53 qtrs — |
| 65 | GAGNON SECURITIES LLC | 29.1K +322.0 (+1.1%) | 4.15M +698.9K (+20.3%) | 0.12% +0.001 pp | 0.84% +0.153 pp | USD145.08 -1.7% | 12 qtrs — |
| 66 | ALLIANCEBERNSTEIN L.P. | 28.9K +1.5K (+5.4%) | 4.13M +835.1K (+25.4%) | 0.12% +0.006 pp | 0.00% +0.000 pp | USD132.93 +7.3% | 61 qtrs — |
| 67 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 28.1K -100.0 (-0.4%) | 4.01M +626.0K (+18.5%) | 0.11% -0.001 pp | 0.01% +0.001 pp | USD123.61 +15.4% | 51 qtrs — |
| 68 | WELLS FARGO & COMPANY/MN | 27.3K +10.9K (+67.0%) | 3.89M +1.9M (+98.6%) | 0.11% +0.044 pp | 0.00% +0.000 pp | USD132.78 +7.4% | 57 qtrs — |
| 69 | STATE OF WISCONSIN INVESTMENT BOARD | 26.5K +20.1K (+309.6%) | 3.79M +3.0M (+387.2%) | 0.11% +0.081 pp | 0.01% +0.007 pp | USD141.13 +1.1% | 31 qtrs — |
| 70 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 25.0K -94.9K (-79.1%) | 3.57M -10.8M (-75.2%) | 0.10% -0.385 pp | 0.01% -0.017 pp | USD119.96 +18.9% | 2 qtrs — |
| 71 | GOTHAM ASSET MANAGEMENT, LLC | 24.7K -16.3K (-39.7%) | 3.53M -1.4M (-28.3%) | 0.10% -0.066 pp | 0.01% -0.009 pp | USD136.38 +4.6% | 8 qtrs — |
| 72 | PRICE T ROWE ASSOCIATES INC /MD/ | 24.0K +1.0K (+4.4%) | 3.42M +665.0K (+24.1%) | 0.10% +0.004 pp | 0.00% +0.000 pp | USD181.11 -21.2% | 70 qtrs — |
| 73 | GAMCO INVESTORS, INC. ET AL | 24.0K -1.1K (-4.3%) | 3.42M +413.9K (+13.8%) | 0.10% -0.005 pp | 0.03% +0.004 pp | USD89.85 +58.8% | 64 qtrs — |
| 74 | DEUTSCHE BANK AG\ | 23.4K +880.0 (+3.9%) | 3.33M +636.0K (+23.6%) | 0.09% +0.003 pp | 0.00% +0.000 pp | USD143.13 -0.3% | 50 qtrs — |
| 75 | AMERICAN CENTURY COMPANIES INC | 23.0K +16.7K (+267.5%) | 3.28M +2.5M (+337.0%) | 0.09% +0.068 pp | 0.00% +0.001 pp | USD136.49 +4.5% | 7 qtrs — |
| 76 | EMERALD MUTUAL FUND ADVISERS TRUST | 22.0K +12.8K (+140.6%) | 3.14M +2.0M (+186.2%) | 0.09% +0.052 pp | 0.15% +0.096 pp | USD133.23 +7.1% | 2 qtrs — |
| 77 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 22.0K -437.0 (-1.9%) | 3.14M +446.7K (+16.6%) | 0.09% -0.002 pp | 0.00% +0.000 pp | USD123.84 +15.2% | 52 qtrs — |
| 78 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 21.6K -4.7K (-17.9%) | 3.07M +5.0K (+0.2%) | 0.09% -0.019 pp | 0.01% +0.001 pp | USD156.83 -9.0% | 49 qtrs — |
| 79 | NEW YORK STATE COMMON RETIREMENT FUND | 20.2K -462.0 (-2.2%) | 2.89M +404.0K (+16.3%) | 0.08% -0.002 pp | 0.00% +0.001 pp | USD180.15 -20.8% | 83 qtrs — |
| 80 | CAMPBELL & CO INVESTMENT ADVISER LLC | 19.5K +19.5K (+100.0%) | 2.78M +2.8M (+100.0%) | 0.08% +0.079 pp | 0.13% +0.133 pp | USD142.67 +0.0% | 5 qtrs — |
| 81 | QUBE RESEARCH & TECHNOLOGIES LTD | 18.8K +15.1K (+403.6%) | 2.68M +2.2M (+499.0%) | 0.08% +0.061 pp | 0.00% +0.002 pp | USD143.27 -0.4% | 5 qtrs — |
| 82 | FRANKLIN RESOURCES INC | 18.2K -742.0 (-3.9%) | 2.60M +325.1K (+14.3%) | 0.07% -0.003 pp | 0.00% +0.000 pp | USD164.87 -13.5% | 18 qtrs — |
| 83 | PACIFIC CAPITAL PARTNERS LTD | 17.8K -44.8K (-71.6%) | 2.53M -5.0M (-66.2%) | 0.07% -0.182 pp | 2.69% -5.658 pp | USD121.58 +17.3% | 10 qtrs — |
| 84 | STATE OF NEW JERSEY COMMON PENSION FUND D | 16.1K -1.4K (-7.9%) | 2.30M +200.0K (+9.5%) | 0.07% -0.006 pp | 0.01% +0.001 pp | USD139.43 +2.3% | 19 qtrs — |
| 85 | ENVESTNET ASSET MANAGEMENT INC | 14.7K -2.3K (-13.4%) | 2.10M +61.7K (+3.0%) | 0.06% -0.009 pp | 0.00% +0.000 pp | USD150.68 -5.3% | 51 qtrs — |
| 86 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 14.0K +149.0 (+1.1%) | 2.00M +336.0K (+20.2%) | 0.06% +0.001 pp | 0.02% +0.004 pp | USD132.27 +7.9% | 37 qtrs — |
| 87 | ILLINOIS MUNICIPAL RETIREMENT FUND | 13.5K +1.2K (+9.4%) | 1.92M +444.8K (+30.2%) | 0.05% +0.005 pp | 0.02% +0.005 pp | USD125.50 +13.7% | 9 qtrs — |
| 88 | METLIFE INVESTMENT MANAGEMENT, LLC | 13.3K -103.3K (-88.6%) | 1.90M -12.1M (-86.4%) | 0.05% -0.419 pp | 0.01% -0.058 pp | USD139.80 +2.1% | 33 qtrs — |
| 89 | CITIGROUP INC | 12.0K -2.0K (-14.0%) | 1.71M +37.6K (+2.3%) | 0.05% -0.008 pp | 0.00% +0.000 pp | USD141.11 +1.1% | 54 qtrs — |
| 90 | IEQ CAPITAL, LLC | 11.5K +3.5K (+43.7%) | 1.64M +679.0K (+70.9%) | 0.05% +0.014 pp | 0.00% +0.002 pp | USD126.87 +12.5% | 2 qtrs — |
| 91 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11.4K -214.4K (-94.9%) | 1.63M -25.5M (-94.0%) | 0.05% -0.870 pp | 0.00% -0.021 pp | USD134.27 +6.3% | 51 qtrs — |
| 92 | LOUISIANA STATE EMPLOYEES RETIREMENT SYSTEM | 11.3K +— (+0.0%) | 1.61M +256.6K (+18.9%) | 0.05% 0.000 pp | 0.03% +0.005 pp | USD122.13 +16.8% | 49 qtrs — |
| 93 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11.2K -1.0 (0.0%) | 1.60M +255.0K (+18.9%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD177.56 -19.6% | 6 qtrs — |
| 94 | CREATIVE PLANNING | 11.0K +2.8K (+34.5%) | 1.57M +588.6K (+60.0%) | 0.04% +0.011 pp | 0.00% +0.000 pp | USD135.17 +5.5% | 8 qtrs — |
| 95 | MOODY NATIONAL BANK TRUST DIVISION | 10.7K +5.0 (+0.0%) | 1.53M +244.6K (+19.0%) | 0.04% 0.000 pp | 0.15% +0.039 pp | USD134.44 +6.1% | 14 qtrs — |
| 96 | COLONY GROUP, LLC | 9.6K +9.6K (+100.0%) | 1.37M +1.4M (+100.0%) | 0.04% +0.039 pp | 0.00% +0.002 pp | USD142.67 +0.0% | 1 qtrs NEW |
| 97 | AQR CAPITAL MANAGEMENT LLC | 9.5K +808.0 (+9.2%) | 1.36M +313.8K (+29.9%) | 0.04% +0.003 pp | 0.00% +0.000 pp | USD117.31 +21.6% | 8 qtrs — |
| 98 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 9.5K -18.5K (-66.1%) | 1.35M -2.0M (-59.7%) | 0.04% -0.075 pp | 0.00% -0.006 pp | USD196.65 -27.4% | 38 qtrs — |
| 99 | INTECH INVESTMENT MANAGEMENT LLC | 9.5K -1.2K (-10.9%) | 1.35M +75.8K (+5.9%) | 0.04% -0.005 pp | 0.01% +0.001 pp | USD152.67 -6.6% | 6 qtrs — |
| 100 | EQUITABLE TRUST CO | 9.3K +815.0 (+9.6%) | 1.33M +309.7K (+30.3%) | 0.04% +0.003 pp | 0.06% +0.013 pp | USD145.60 -2.0% | 18 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 148 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | F/M Emerald Life Sciences Innovation ETF LFSC | 2.03% | 1.52M | 0.54% |
| 2 | State Street SPDR S&P Health Care Equipment ETF XHE | 1.73% | 2.62M | 0.35% |
| 3 | Invesco S&P SmallCap Health Care ETF PSCH | 1.69% | 2.76M | 0.29% |
| 4 | JPMorgan Active Small Cap Value ETF JPSV | 0.98% | 262.4K | 0.55% |
| 5 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.57% | 125.0K | 0.20% |
| 6 | KraneShares Man Buyout Beta Index ETF BUYO | 0.48% | 80.0K | 0.89% |
| 7 | iShares US Small Cap Value Factor ETF SVAL | 0.35% | 699.8K | 0.20% |
| 8 | OneAscent Small Cap Core ETF OASC | 0.34% | 284.6K | 0.64% |
| 9 | iShares Russell 2000 Value ETF IWN | 0.25% | 35.32M | 0.24% |
| 10 | Timothy Plan US Small Cap Core ETF TPSC | 0.23% | 763.0K | 0.52% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.49
Bearish
Ratio by volume
0.65
Neutral
Buys
25
Sells
51
Shares acquired
385.2K
Shares disposed
594.5K
Cash buys
—
Cash sales
—
Net activity
-209,329
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-25 | Abbey Donald | Director | J-Other | D | Common Stock | 704 | 0.00 | — | 4,046 | D | ↗ |
| 2026-03-15 | Woolson Daniel | Officer | M-Exempt | A | Common Stock | 2,924 | 0.00 | — | 25,897 | D | ↗ |
| 2026-03-15 | Voigtlander Christian B. | Officer | M-Exempt | D | Performance Shares | 11,400 | 0.00 | — | 0 | D | ↗ |
| 2026-03-15 | Sousa Ben | Officer | M-Exempt | A | Common Stock | 1,300 | 0.00 | — | 6,044 | D | ↗ |
| 2026-03-15 | Sanzone Virginia Ruth | Officer | F-InKind | D | Common Stock | 897 | 125.85 | 112.9K | 21,907 | D | ↗ |
| 2026-03-15 | Jain Vivek | Director / Officer | M-Exempt | D | Performance Shares | 17,100 | 0.00 | — | 0 | D | ↗ |
| 2026-03-15 | Bonnell Brian Michael | Officer | M-Exempt | D | Common Stock | 3,248 | 0.00 | — | 0 | D | ↗ |
| 2026-03-08 | Woolson Daniel | Officer | M-Exempt | D | Common Stock | 2,153 | 0.00 | — | 6,908 | D | ↗ |
| 2026-03-08 | Voigtlander Christian B. | Officer | F-InKind | D | Common Stock | 39,667 | 132.00 | 5.24M | 39,754 | D | ↗ |
| 2026-03-08 | Sousa Ben | Officer | F-InKind | D | Common Stock | 3,967 | 132.00 | 523.6K | 4,316 | D | ↗ |
| 2026-03-08 | Sanzone Virginia Ruth | Officer | M-Exempt | A | Common Stock | 3,189 | 0.00 | — | 20,392 | D | ↗ |
| 2026-03-08 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 107,635 | 0.00 | — | 176,506 | D | ↗ |
| 2026-03-08 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 71,757 | 0.00 | — | 104,364 | D | ↗ |
| 2026-03-07 | Woolson Daniel | Officer | M-Exempt | D | Performance Shares | 1,585 | 0.00 | — | 3,170 | D | ↗ |
| 2026-03-07 | Voigtlander Christian B. | Officer | M-Exempt | A | Common Stock | 3,522 | 0.00 | — | 9,610 | D | ↗ |
| 2026-03-07 | Sousa Ben | Officer | M-Exempt | D | Common Stock | 1,409 | 0.00 | — | 4,732 | D | ↗ |
| 2026-03-07 | Sanzone Virginia Ruth | Officer | F-InKind | D | Common Stock | 1,297 | 132.00 | 171.2K | 6,507 | D | ↗ |
| 2026-03-07 | Jain Vivek | Director / Officer | F-InKind | D | Common Stock | 2,919 | 0.00 | — | 68,871 | D | ↗ |
| 2026-03-07 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 3,522 | 0.00 | — | 33,870 | D | ↗ |
| 2025-11-25 | Woolson Daniel | Officer | S-Sale | D | Common Stock | 2,897 | 152.35 | 441.4K | 11,297 | D | ↗ |
| 2025-11-11 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 930 | 142.35 | 132.4K | 5,456 | D | ↗ |
| 2025-11-11 | FINNEY ELISHA W | Director | M-Exempt | A | Common Stock | 1,285 | 103.76 | 133.3K | 5,280 | D | ↗ |
| 2025-09-12 | Jain Vivek | Director / Officer | G-Gift | A | Common Stock | 63,641 | 0.00 | — | 152,339 | I | ↗ |
| 2025-08-27 | Greenberg David C. | Director | P-Purchase | A | Common Stock | 602 | 126.14 | 75.9K | 7,362 | D | ↗ |
| 2025-08-14 | Jain Vivek | Director / Officer | P-Purchase | A | Common Stock | 2,378 | 112.12 | 266.6K | 110,598 | D | ↗ |
| 2025-05-30 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 700 | 133.62 | 93.5K | 6,386 | D | ↗ |
| 2025-05-28 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,560 | 96.83 | 538.4K | 0 | D | ↗ |
| 2025-05-27 | Voigtlander Christian B. | Officer | M-Exempt | A | Common Stock | 5,555 | 96.83 | 537.9K | 10,458 | D | ↗ |
| 2025-05-23 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,555 | 96.83 | 537.9K | 11,115 | D | ↗ |
| 2025-05-22 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,555 | 96.83 | 537.9K | 16,670 | D | ↗ |
| 2025-05-21 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,555 | 96.83 | 537.9K | 22,225 | D | ↗ |
| 2025-05-20 | Voigtlander Christian B. | Officer | M-Exempt | A | Common Stock | 5,555 | 96.83 | 537.9K | 7,944 | D | ↗ |
| 2025-05-19 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,555 | 96.83 | 537.9K | 33,335 | D | ↗ |
| 2025-05-19 | FINNEY ELISHA W | Director | S-Sale | D | Common Stock | 600 | 138.92 | 83.4K | 3,252 | D | ↗ |
| 2025-05-16 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,555 | 96.83 | 537.9K | 38,890 | D | ↗ |
| 2025-05-15 | Voigtlander Christian B. | Officer | M-Exempt | A | Common Stock | 5,555 | 96.83 | 537.9K | 7,944 | D | ↗ |
| 2025-05-15 | Sousa Ben | Officer | S-Sale | D | Common Stock | 2,000 | 137.36 | 274.7K | 479 | D | ↗ |
| 2025-05-14 | Voigtlander Christian B. | Officer | S-Sale | D | Common Stock | 5,556 | 138.65 | 770.3K | 2,389 | D | ↗ |
| 2025-05-13 | KENNEDY KOLLEEN T | Director | M-Exempt | A | Common Stock | 1,723 | 0.00 | — | 3,285 | D | ↗ |
| 2025-05-13 | Hoffmeister David F | Director | M-Exempt | A | Common Stock | 1,723 | 0.00 | — | 4,750 | D | ↗ |
| 2025-05-13 | Hernandez Laurie | Director | M-Exempt | D | Common Stock | 1,723 | 0.00 | — | 0 | D | ↗ |
| 2025-05-13 | Greenberg David C. | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 1,942 | 94.68 | 183.9K | 0 | D | ↗ |
| 2025-05-13 | FINNEY ELISHA W | Director | M-Exempt | A | Common Stock | 1,723 | 0.00 | — | 3,852 | D | ↗ |
| 2025-05-13 | Abbey Donald | Director | A-Award | A | Common Stock | 1,254 | 0.00 | — | 1,254 | D | ↗ |
| 2025-03-15 | Woolson Daniel | Officer | M-Exempt | D | Performance Shares | 2,923 | 0.00 | — | 2,924 | D | ↗ |
| 2025-03-15 | Voigtlander Christian B. | Officer | F-InKind | D | Common Stock | 1,792 | 143.45 | 257.1K | 2,389 | D | ↗ |
| 2025-03-15 | Sousa Ben | Officer | M-Exempt | A | Common Stock | 1,299 | 0.00 | — | 3,195 | D | ↗ |
| 2025-03-15 | Sanzone Virginia Ruth | Officer | M-Exempt | D | Common Stock | 1,624 | 0.00 | — | 1,624 | D | ↗ |
| 2025-03-15 | Jain Vivek | Director / Officer | M-Exempt | D | Common Stock | 4,872 | 0.00 | — | 4,872 | D | ↗ |
| 2025-03-15 | Bonnell Brian Michael | Officer | M-Exempt | D | Common Stock | 3,248 | 0.00 | — | 3,248 | D | ↗ |
| 2025-03-08 | Woolson Daniel | Officer | M-Exempt | A | Common Stock | 2,153 | 0.00 | — | 13,518 | D | ↗ |
| 2025-03-08 | Sousa Ben | Officer | F-InKind | D | Common Stock | 550 | 141.97 | 78.1K | 1,896 | D | ↗ |
| 2025-03-08 | Sanzone Virginia Ruth | Officer | F-InKind | D | Common Stock | 1,759 | 141.97 | 249.7K | 6,360 | D | ↗ |
| 2025-03-07 | Woolson Daniel | Officer | M-Exempt | D | Common Stock | 966 | 0.00 | — | 0 | D | ↗ |
| 2025-03-07 | Voigtlander Christian B. | Officer | M-Exempt | D | Common Stock | 2,146 | 0.00 | — | 0 | D | ↗ |
| 2025-03-07 | Sousa Ben | Officer | M-Exempt | D | Common Stock | 430 | 0.00 | — | 0 | D | ↗ |
| 2025-03-07 | Sanzone Virginia Ruth | Officer | A-Award | A | Common Stock | 7,044 | 0.00 | — | 16,612 | D | ↗ |
| 2025-03-07 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 3,218 | 0.00 | — | 106,036 | D | ↗ |
| 2025-03-07 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 2,146 | 0.00 | — | 27,100 | D | ↗ |
| 2025-01-02 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 1,373 | 88.76 | 121.9K | 105,966 | D | ↗ |
| 2024-12-06 | Woolson Daniel | Officer | S-Sale | D | Common Stock | 2,241 | 156.25 | 350.2K | 10,866 | D | ↗ |
| 2024-12-02 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 12,000 | 88.76 | 1.07M | 116,593 | D | ↗ |
| 2024-11-27 | Voigtlander Christian B. | Officer | S-Sale | D | Common Stock | 1,430 | 158.00 | 225.9K | 0 | D | ↗ |
| 2024-11-27 | Greenberg David C. | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 972 | 94.68 | 92.0K | 1,942 | D | ↗ |
| 2024-11-26 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 7,719 | 96.83 | 747.4K | 56,986 | D | ↗ |
| 2024-11-25 | Voigtlander Christian B. | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 1,962 | 96.83 | 190.0K | 64,705 | D | ↗ |
| 2024-11-01 | Jain Vivek | Director / Officer | S-Sale | D | Common Stock | 4,147 | 171.91 | 712.9K | 108,218 | D | ↗ |
| 2024-10-01 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 12,000 | 88.76 | 1.07M | 116,593 | D | ↗ |
| 2024-09-03 | Jain Vivek | Director / Officer | S-Sale | D | Common Stock | 4,440 | 163.59 | 726.3K | 104,593 | — | ↗ |
| 2024-08-30 | Woolson Daniel | Officer | S-Sale | D | Common Stock | 2,502 | 163.22 | 408.4K | 13,107 | — | ↗ |
| 2024-08-16 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 12,000 | 88.76 | 1.07M | 116,593 | — | ↗ |
| 2024-08-08 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 2,050 | 144.11 | 295.4K | 4,482 | — | ↗ |
| 2024-05-30 | Voigtlander Christian B. | Officer | S-Sale | D | Common Stock | 10,507 | 103.85 | 1.09M | 2,032 | — | ↗ |
| 2024-05-16 | FINNEY ELISHA W | Director | S-Sale | D | Common Stock | 300 | 104.95 | 31.5K | 2,129 | — | ↗ |
| 2024-05-15 | KENNEDY KOLLEEN T | Director | M-Exempt | D | Common Stock | 948 | 0.00 | — | 0 | — | ↗ |
| 2024-05-15 | Hoffmeister David F | Director | M-Exempt | D | Common Stock | 948 | 0.00 | — | 0 | — | ↗ |
| 2024-05-15 | Hernandez Laurie | Director | M-Exempt | D | Common Stock | 948 | 0.00 | — | 0 | — | ↗ |
| 2024-05-15 | Greenberg David C. | Director | M-Exempt | D | Common Stock | 948 | 0.00 | — | 0 | — | ↗ |
| 2024-05-15 | FINNEY ELISHA W | Director | M-Exempt | A | COmmon Stock | 948 | 0.00 | — | 2,429 | — | ↗ |
| 2024-05-15 | Abbey Donald | Director | A-Award | A | Common Stock | 1,723 | 0.00 | — | 0 | — | ↗ |
| 2024-05-10 | Sousa Ben | Officer | S-Sale | D | Common Stock | 2,000 | 105.55 | 211.1K | 1,319 | — | ↗ |
| 2024-03-15 | Woolson Daniel | Officer | S-Sale | D | Common Stock | 791 | 98.27 | 77.7K | 13,980 | — | ↗ |
| 2024-03-15 | Voigtlander Christian B. | Officer | M-Exempt | D | Common Stock | 3,247 | 0.00 | — | 6,496 | — | ↗ |
| 2024-03-15 | Sousa Ben | Officer | M-Exempt | A | Common Stock | 1,299 | 0.00 | — | 3,782 | — | ↗ |
| 2024-03-15 | Sanzone Virginia Ruth | Officer | M-Exempt | D | Common Stock | 1,624 | 0.00 | — | 3,248 | — | ↗ |
| 2024-03-15 | Jain Vivek | Director / Officer | F-InKind | D | Common Stock | 2,671 | 98.08 | 262.0K | 104,593 | — | ↗ |
| 2024-03-15 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 3,247 | 0.00 | — | 26,734 | — | ↗ |
| 2024-03-14 | LOPEZ GEORGE A | Director | S-Sale | D | Common Stock | 7,978 | 101.87 | 812.7K | 877,343 | — | ↗ |
| 2024-03-12 | LOPEZ GEORGE A | Director | S-Sale | D | Common Stock | 1,522 | 101.51 | 154.5K | 316,231 | — | ↗ |
| 2024-03-11 | LOPEZ GEORGE A | Director | S-Sale | D | Common Stock | 1,890 | 104.22 | 197.0K | 317,753 | — | ↗ |
| 2024-03-08 | Woolson Daniel | Officer | F-InKind | D | Common Stock | 894 | 104.52 | 93.4K | 14,771 | — | ↗ |
| 2024-03-08 | Voigtlander Christian B. | Officer | M-Exempt | D | Common Stock | 2,210 | 0.00 | — | 0 | — | ↗ |
| 2024-03-08 | Sousa Ben | Officer | M-Exempt | D | Common Stock | 674 | 0.00 | — | 0 | — | ↗ |
| 2024-03-08 | Sanzone Virginia Ruth | Officer | M-Exempt | A | Common Stock | 2,273 | 0.00 | — | 7,044 | — | ↗ |
| 2024-03-08 | LOPEZ GEORGE A | Director | S-Sale | D | Common Stock | 15,372 | 105.94 | 1.63M | 319,643 | — | ↗ |
| 2024-03-08 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 8,331 | 0.00 | — | 106,962 | — | ↗ |
| 2024-03-08 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 7,289 | 0.00 | — | 27,485 | — | ↗ |
| 2024-03-07 | Woolson Daniel | Officer | F-InKind | D | Common Stock | 2,564 | 105.39 | 270.2K | 13,645 | — | ↗ |
| 2024-03-07 | Voigtlander Christian B. | Officer | M-Exempt | A | Common Stock | 12,872 | 0.00 | — | 13,842 | — | ↗ |
| 2024-03-07 | Sousa Ben | Officer | M-Exempt | D | Common Stock | 429 | 0.00 | — | 430 | — | ↗ |
| 2024-03-07 | Sanzone Virginia Ruth | Officer | M-Exempt | A | Common Stock | 1,073 | 0.00 | — | 5,751 | — | ↗ |
| 2024-03-07 | LOPEZ GEORGE A | Director | S-Sale | D | Common Stock | 18,954 | 105.77 | 2.00M | 335,015 | — | ↗ |
| 2024-03-07 | Jain Vivek | Director / Officer | F-InKind | D | Common Stock | 10,588 | 105.39 | 1.12M | 97,490 | — | ↗ |
| 2024-03-07 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 12,872 | 0.00 | — | 26,257 | — | ↗ |
| 2024-03-04 | Voigtlander Christian B. | Officer | S-Sale | D | Common Stock | 6,887 | 106.77 | 735.3K | 6,716 | — | ↗ |
| 2024-03-04 | LOPEZ GEORGE A | Director | S-Sale | D | Common Stock | 7,051 | 106.79 | 753.0K | 353,969 | — | ↗ |
| 2024-02-29 | Smiths Group International Holdings Ltd | 10% Owner | S-Sale | D | Common Stock | 830,000 | 106.08 | 88.04M | 1,670,000 | — | ↗ |
| 2024-02-29 | SMITHS GROUP PLC | 10% Owner | S-Sale | D | Common Stock | 830,000 | 106.08 | 88.04M | 1,670,000 | — | ↗ |
| 2024-02-15 | Sousa Ben | Officer | — | D | Common Stock | 0 | 0.00 | — | 123 | — | ↗ |
| 2024-02-12 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 66,000 | 58.79 | 3.88M | 126,000 | — | ↗ |
| 2023-12-01 | Woolson Daniel | Officer | S-Sale | D | Common Stock | 1,729 | 88.03 | 152.2K | 9,877 | — | ↗ |
| 2023-09-08 | Voigtlander Christian B. | Officer | S-Sale | D | Common Stock | 6,162 | 128.97 | 794.7K | 14,291 | — | ↗ |
| 2023-07-12 | Jain Vivek | Director / Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 30,000 | 58.79 | 1.76M | 146,366 | — | ↗ |
| 2023-06-14 | Jain Vivek | Director / Officer | S-Sale | D | Common Stock | 100 | 194.73 | 19.5K | 25,781 | — | ↗ |
| 2023-06-07 | FINNEY ELISHA W | Director | S-Sale | D | Common Stock | 194 | 190.41 | 36.9K | 1,481 | — | ↗ |
| 2023-06-02 | Jain Vivek | Director / Officer | G-Gift | D | Common Stock | 85 | 0.00 | — | 23,677 | — | ↗ |
| 2023-05-17 | Voigtlander Christian B. | Officer | A-Award | A | Common Stock | 9,743 | 0.00 | — | 9,743 | — | ↗ |
| 2023-05-17 | Sanzone Virginia Ruth | Officer | A-Award | A | Common Stock | 4,872 | 0.00 | — | 4,872 | — | ↗ |
| 2023-05-17 | KENNEDY KOLLEEN T | Director | A-Award | A | Common Stock | 948 | 0.00 | — | 948 | — | ↗ |
| 2023-05-17 | Jain Vivek | Director / Officer | A-Award | A | Common Stock | 14,615 | 0.00 | — | 14,615 | — | ↗ |
| 2023-05-17 | Hoffmeister David F | Director | M-Exempt | D | Common Stock | 485 | 0.00 | — | 0 | — | ↗ |
| 2023-05-17 | Hernandez Laurie | Director | M-Exempt | A | Common Stock | 485 | 0.00 | — | 937 | — | ↗ |
| 2023-05-17 | Greenberg David C. | Director | M-Exempt | D | Common Stock | 485 | 0.00 | — | 0 | — | ↗ |
| 2023-05-17 | FINNEY ELISHA W | Director | M-Exempt | D | Common Stock | 485 | 0.00 | — | 0 | — | ↗ |
| 2023-05-17 | Bonnell Brian Michael | Officer | A-Award | A | Common Stock | 9,743 | 0.00 | — | 9,743 | — | ↗ |
| 2023-05-17 | Abbey Donald | Director | M-Exempt | A | Common Stock | 485 | 0.00 | — | 2,079 | — | ↗ |
| 2023-04-11 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 250 | 175.00 | 43.8K | 4,678 | — | ↗ |
| 2023-04-05 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 458 | 170.00 | 77.9K | 4,928 | — | ↗ |
| 2023-03-08 | Woolson Daniel | Officer | M-Exempt | D | Performance Shares | 2,020 | 0.00 | — | 2,020 | — | ↗ |
| 2023-03-08 | Voigtlander Christian B. | Officer | M-Exempt | A | Common Stock | 2,209 | 0.00 | — | 21,616 | — | ↗ |
| 2023-03-08 | Sanzone Virginia Ruth | Officer | M-Exempt | D | Performance Shares | 2,272 | 0.00 | — | 2,273 | — | ↗ |
| 2023-03-08 | Jain Vivek | Director / Officer | M-Exempt | D | Common Stock | 2,525 | 0.00 | — | 2,525 | — | ↗ |
| 2023-03-08 | Bonnell Brian Michael | Officer | M-Exempt | D | Common Stock | 2,209 | 0.00 | — | 2,210 | — | ↗ |
| 2023-03-07 | Woolson Daniel | Officer | M-Exempt | D | Common Stock | 965 | 0.00 | — | 1,932 | — | ↗ |
| 2023-03-07 | Voigtlander Christian B. | Officer | F-InKind | D | Common Stock | 1,129 | 157.47 | 177.8K | 19,407 | — | ↗ |
| 2023-03-07 | Sanzone Virginia Ruth | Officer | M-Exempt | A | Common Stock | 1,072 | 0.00 | — | 4,874 | — | ↗ |
| 2023-03-07 | Jain Vivek | Director / Officer | M-Exempt | D | Common Stock | 3,218 | 0.00 | — | 6,436 | — | ↗ |
| 2023-03-07 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 2,145 | 0.00 | — | 12,498 | — | ↗ |
| 2023-03-06 | Woolson Daniel | Officer | M-Exempt | A | Common Stock | 1,417 | 0.00 | — | 10,569 | — | ↗ |
| 2023-03-06 | Voigtlander Christian B. | Officer | F-InKind | D | Common Stock | 816 | 161.25 | 131.6K | 18,391 | — | ↗ |
| 2023-03-06 | Sanzone Virginia Ruth | Officer | M-Exempt | A | Common Stock | 1,595 | 0.00 | — | 4,641 | — | ↗ |
| 2023-03-06 | Jain Vivek | Director / Officer | M-Exempt | D | Common Stock | 1,773 | 0.00 | — | 0 | — | ↗ |
| 2023-03-06 | Bonnell Brian Michael | Officer | M-Exempt | A | Common Stock | 8,745 | 0.00 | — | 14,957 | — | ↗ |
| 2023-02-02 | Woolson Daniel | Officer | S-Sale | D | Common Stock | 1,731 | 200.00 | 346.2K | 9,152 | — | ↗ |
| 2022-11-15 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 325 | 160.12 | 52.0K | 3,046 | — | ↗ |
| 2022-09-21 | LOPEZ GEORGE A | Director | M-Exempt | A | Common Stock | 79,576 | 61.76 | 4.91M | 361,020 | — | ↗ |
| 2022-05-23 | Jain Vivek | Officer | G-Gift | D | Common Stock | 30 | 0.00 | — | 15,469 | — | ↗ |
| 2022-05-17 | KENNEDY KOLLEEN T | Director | A-Award | A | Common Stock | 485 | 0.00 | — | 485 | — | ↗ |
| 2022-05-17 | Hoffmeister David F | Director | A-Award | A | Common Stock | 485 | 0.00 | — | 485 | — | ↗ |
| 2022-05-17 | Hernandez Laurie | Director | A-Award | A | Common Stock | 485 | 0.00 | — | 485 | — | ↗ |
| 2022-05-17 | Greenberg David C. | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 1,270 | 185.79 | 236.0K | 1,270 | — | ↗ |
| 2022-05-17 | FINNEY ELISHA W | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 1,270 | 185.79 | 236.0K | 1,270 | — | ↗ |
| 2022-05-17 | Abbey Donald | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 1,270 | 185.79 | 236.0K | 1,270 | — | ↗ |
| 2022-05-13 | FINNEY ELISHA W | Director | A-Award | A | Common Stock | 485 | 0.00 | — | 485 | — | ↗ |
| 2022-05-12 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 750 | 173.56 | 130.2K | 3,371 | — | ↗ |
| 2022-05-12 | LOPEZ GEORGE A | Director | P-Purchase | A | Common Stock | 17 | 174.66 | 3.0K | 281,444 | — | ↗ |
| 2022-05-11 | KENNEDY KOLLEEN T | Director | M-Exempt | D | Common Stock | 129 | 0.00 | — | 0 | — | ↗ |
| 2022-05-11 | Hoffmeister David F | Director | M-Exempt | A | Common Stock | 433 | 0.00 | — | 1,594 | — | ↗ |
| 2022-05-11 | Hernandez Laurie | Director | M-Exempt | D | Common Stock | 352 | 0.00 | — | 0 | — | ↗ |
| 2022-05-11 | Greenberg David C. | Director | M-Exempt | D | Common Stock | 433 | 0.00 | — | 0 | — | ↗ |
| 2022-05-11 | FINNEY ELISHA W | Director | M-Exempt | D | Common Stock | 433 | 0.00 | — | 0 | — | ↗ |
| 2022-05-11 | Abbey Donald | Director | M-Exempt | D | Common Stock | 433 | 0.00 | — | 0 | — | ↗ |
| 2022-03-08 | Woolson Daniel | Officer | M-Exempt | A | Common Stock | 2,020 | 0.00 | — | 11,777 | — | ↗ |
| 2022-03-08 | Sanzone Virginia Ruth | Officer | M-Exempt | D | Performance Shares | 2,272 | 0.00 | — | 4,545 | — | ↗ |
| 2022-03-06 | Woolson Daniel | Officer | M-Exempt | A | Common Stock | 1,418 | 0.00 | — | 10,385 | — | ↗ |
| 2022-03-06 | Voigtlander Christian B. | Officer | F-InKind | D | Common Stock | 1,163 | 0.00 | — | 13,515 | — | ↗ |
| 2022-03-06 | Sanzone Virginia Ruth | Officer | M-Exempt | D | Performance Shares | 1,444 | 0.00 | — | 0 | — | ↗ |
| 2022-03-06 | McGrody Kevin J | Officer | F-InKind | D | Common Stock | 532 | 242.93 | 129.2K | 4,027 | — | ↗ |
| 2022-03-06 | Jain Vivek | Officer | M-Exempt | A | Common Stock | 1,444 | 0.00 | — | 15,063 | — | ↗ |
| 2022-03-06 | Bonnell Brian Michael | Officer | F-InKind | D | Common Stock | 380 | 242.93 | 92.3K | 3,696 | — | ↗ |
| 2022-03-03 | Jain Vivek | Officer | M-Exempt | A | Common Stock | 36,000 | 58.79 | 2.12M | 48,779 | — | ↗ |
| 2022-02-01 | Seeger William | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-06 | Smiths Group International Holdings Ltd | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,500,000 | — | ↗ |
| 2022-01-06 | SMITHS GROUP PLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 2,500,000 | — | ↗ |
| 2021-12-31 | KENNEDY KOLLEEN T | Director | A-Award | A | Non-qualified Stock Option (right to buy) | 380 | 237.34 | 90.2K | 380 | — | ↗ |
| 2021-12-30 | Jain Vivek | Director / Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 1,159 | 58.79 | 68.1K | 242,366 | — | ↗ |
| 2021-12-29 | Jain Vivek | Director / Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 10,677 | 58.79 | 627.7K | 243,525 | — | ↗ |
| 2021-12-28 | Jain Vivek | Director / Officer | M-Exempt | A | Common Stock | 164 | 58.79 | 9.6K | 12,943 | — | ↗ |
| 2021-11-03 | Jain Vivek | Director / Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 12,000 | 58.79 | 705.5K | 266,366 | — | ↗ |
| 2021-09-15 | SWINNEY ROBERT S | Director | S-Sale | D | Common Stock | 2,157 | 243.00 | 524.2K | 20,816 | — | ↗ |
| 2021-09-14 | LOPEZ GEORGE A | Director / 10% Owner | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 15,295 | 46.53 | 711.7K | 0 | — | ↗ |
| 2021-09-14 | FINNEY ELISHA W | Director | M-Exempt | D | Non Qualified Stock Options (Iright to buy) | 2,424 | 101.06 | 245.0K | 0 | — | ↗ |
| 2021-09-10 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 151 | 250.23 | 37.8K | 2,254 | — | ↗ |
| 2021-07-01 | Hernandez Laurie | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 1,055 | 208.16 | 219.6K | 1,055 | — | ↗ |
| 2021-06-03 | SWINNEY ROBERT S | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 1,500 | 39.38 | 59.1K | 0 | — | ↗ |
| 2021-05-24 | Jain Vivek | Director / Officer | G-Gift | D | Common Stock | 40 | 0.00 | — | 12,779 | — | ↗ |
| 2021-05-20 | Jain Vivek | Director / Officer | G-Gift | D | Common Stock | 25 | 0.00 | — | 12,819 | — | ↗ |
| 2021-05-11 | Sanzone Virginia Ruth | Officer | S-Sale | D | Common Stock | 983 | 200.11 | 196.7K | 2,405 | — | ↗ |
| 2021-05-11 | SWINNEY ROBERT S | Director | M-Exempt | D | Common Stock | 468 | 0.00 | — | 0 | — | ↗ |
| 2021-05-11 | Hoffmeister David F | Director | M-Exempt | D | Common Stock | 468 | 0.00 | — | 0 | — | ↗ |
| 2021-05-11 | Greenberg David C. | Director | M-Exempt | D | Common Stock | 468 | 0.00 | — | 0 | — | ↗ |
| 2021-05-11 | FINNEY ELISHA W | Director | M-Exempt | D | Common Stock | 468 | 0.00 | — | 0 | — | ↗ |
| 2021-05-11 | Abbey Donald | Director | A-Award | A | Common Stock | 433 | 0.00 | — | 433 | — | ↗ |
| 2021-04-23 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 2,671 | 211.82 | 565.8K | 897,187 | — | ↗ |
| 2021-04-22 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 1,970 | 215.29 | 424.1K | 899,858 | — | ↗ |
| 2021-04-16 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 1,454 | 207.65 | 301.9K | 920,489 | — | ↗ |
| 2021-04-15 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 200 | 209.31 | 41.9K | 921,943 | — | ↗ |
| 2021-04-12 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 4,149 | 206.10 | 855.1K | 937,227 | — | ↗ |
| 2021-04-09 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 400 | 204.70 | 81.9K | 941,543 | — | ↗ |
| 2021-04-08 | LOPEZ GEORGE A | Director / 10% Owner | S-Sale | D | Common Stock | 2,868 | 204.00 | 585.1K | 953,061 | — | ↗ |
Executive team
Top executives
EBIT / Employee
7.2K
Shares Outstanding
24.99M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 775.0K | — | 4.50M | — | 1.16M | 14.5K | 6.45M | 69.75% | ↗ |
| 2 | 2025 | Christian Voigtlander, Chief Operating Officer | 500.0K | — | 3.00M | — | 450.0K | — | 3.95M | 75.95% | ↗ |
| 3 | 2025 | Brian Bonnell, Chief Financial Officer | 475.0K | — | 3.00M | — | 427.5K | — | 3.90M | 76.87% | ↗ |
| 4 | 2025 | Virginia Sanzone, Corporate Vice President, General Counsel | 430.0K | — | 2.00M | — | 387.0K | — | 2.82M | 71.00% | ↗ |
| 5 | 2025 | Daniel Woolson, Corporate Vice President, General Manager - Infusion Systems | 395.2K | — | 1.35M | — | 360.0K | 11.5K | 2.12M | 63.78% | ↗ |
| 6 | 2024 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 775.0K | — | 4.50M | — | 1.16M | 17.3K | 6.45M | 69.72% | ↗ |
| 7 | 2024 | Christian Voigtlander, Chief Operating Officer | 500.0K | 75.0K | 3.00M | — | 450.0K | 17.3K | 4.04M | 74.22% | ↗ |
| 8 | 2024 | Brian Bonnell, Chief Financial Officer | 475.0K | 71.3K | 3.00M | — | 427.5K | 17.3K | 3.99M | 75.17% | ↗ |
| 9 | 2024 | Virginia Sanzone, Corporate Vice President, General Counsel | 430.0K | 64.5K | 2.00M | — | 387.0K | 17.3K | 2.90M | 69.00% | ↗ |
| 10 | 2024 | Daniel Woolson, Corporate Vice President, General Manager - Infusion Systems | 375.0K | — | 1.35M | — | 326.3K | 17.3K | 2.07M | 65.27% | ↗ |
| 11 | 2023 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 775.0K | — | 5.55M | — | 465.0K | 16.5K | 6.81M | 81.55% | ↗ |
| 12 | 2023 | Christian Voigtlander, Chief Operating Officer | 500.0K | — | 3.70M | — | 180.0K | 16.5K | 4.40M | 84.17% | ↗ |
| 13 | 2023 | Brian Bonnell, Chief Financial Officer | 475.0K | 23.1K | 3.70M | — | 171.0K | 16.5K | 4.39M | 84.38% | ↗ |
| 14 | 2023 | Virginia Sanzone, Corporate Vice President, General Counsel | 430.0K | 20.9K | 1.85M | — | 154.8K | 16.5K | 2.47M | 74.85% | ↗ |
| 15 | 2023 | Dan Woolson, Corporate Vice President, General Manager - Infusion Systems | 375.0K | 17.6K | 1.67M | — | 135.0K | 16.5K | 2.21M | 75.39% | ↗ |
| 16 | 2023 | Daniel Woolson, Corporate Vice President, General Manager - Infusion Systems | 375.0K | 17.6K | 1.67M | — | 135.0K | 16.5K | 2.21M | 75.39% | ↗ |
| 17 | 2022 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 755.8K | 387.5K | 4.50M | — | — | 13.7K | 5.66M | 79.55% | ↗ |
| 18 | 2022 | Christian Voigtlander, Chief Operating Officer | 487.7K | 150.0K | 3.00M | — | — | 13.7K | 3.65M | 82.16% | ↗ |
| 19 | 2022 | Brian Bonnell, Chief Financial Officer | 462.7K | 142.5K | 3.00M | — | — | 13.7K | 3.62M | 82.90% | ↗ |
| 20 | 2022 | Virginia Sanzone, Corporate Vice President, General Counsel | 410.0K | 129.0K | 1.50M | — | — | 13.7K | 2.05M | 73.07% | ↗ |
| 21 | 2022 | Dan Woolson, Corporate Vice President, General Manager - Infusion Systems | 363.5K | 112.5K | 1.35M | — | — | 13.7K | 1.84M | 73.39% | ↗ |
| 22 | 2022 | Daniel Woolson, Corporate Vice President, General Manager - Infusion Systems | 363.5K | 112.5K | 1.35M | — | — | 13.7K | 1.84M | 73.39% | ↗ |
| 23 | 2021 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | — | 3.76M | — | 650.0K | 13.5K | 5.07M | 74.10% | ↗ |
| 24 | 2021 | Christian Voigtlander, Chief Operating Officer | 420.0K | — | 3.29M | — | 252.0K | 13.5K | 3.97M | 82.75% | ↗ |
| 25 | 2021 | Brian Bonnell, Chief Financial Officer | 395.0K | — | 3.29M | — | 237.0K | 13.5K | 3.93M | 83.59% | ↗ |
| 26 | 2021 | Virginia Sanzone, Corporate Vice President, General Counsel | 300.0K | 30.0K | 1.35M | — | 180.0K | 13.5K | 1.87M | 72.06% | ↗ |
| 27 | 2021 | Dan Woolson, Corporate Vice President, General Manager - Infusion Systems | 300.0K | — | 1.20M | — | 180.0K | 13.5K | 1.69M | 70.86% | ↗ |
| 28 | 2020 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | 84.5K | 2.00M | — | 565.5K | 12.8K | 3.31M | 60.37% | ↗ |
| 29 | 2020 | Christian Voigtlander, Chief Operating Officer | 420.0K | 32.8K | 1.75M | — | 219.2K | 12.8K | 2.44M | 71.88% | ↗ |
| 30 | 2020 | Brian Bonnell, Chief Financial Officer | 395.0K | 30.8K | 1.75M | — | 206.2K | 12.8K | 2.40M | 73.08% | ↗ |
| 31 | 2020 | Virginia Sanzone, Corporate Vice President, General Counsel | 300.0K | 23.4K | 900.1K | — | 156.6K | 12.8K | 1.39M | 64.62% | ↗ |
| 32 | 2020 | Dan Woolson, Corporate Vice President, General Manager - Infusion Systems | 300.0K | 23.4K | 800.0K | — | 156.6K | 12.8K | 1.29M | 61.88% | ↗ |
| 33 | 2020 | Scott Lamb, Former Chief Financial Officer and Treasurer | 69.5K | — | — | — | — | 78.8K | 148.3K | 0.00% | ↗ |
| 34 | 2019 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | 162.5K | 2.00M | — | — | 12.4K | 2.83M | 70.80% | ↗ |
| 35 | 2019 | Christian Voigtlander, Chief Operating Officer | 420.0K | 63.0K | 2.00M | — | — | 12.4K | 2.50M | 80.15% | ↗ |
| 36 | 2019 | Dan Woolson, Corporate Vice President, General Manager - Infusion Systems | 300.0K | 90.0K | 1.00M | — | — | 12.4K | 1.40M | 71.31% | ↗ |
| 37 | 2019 | Virginia Sanzone, Corporate Vice President, General Counsel | 300.0K | 90.0K | 1.00M | — | — | 12.4K | 1.40M | 71.31% | ↗ |
| 38 | 2019 | Scott E. Lamb, Former Chief Financial Officer and Treasurer | 395.2K | 118.5K | 600.2K | — | — | 12.4K | 1.13M | 53.29% | ↗ |
| 39 | 2019 | Scott Lamb, Former Chief Financial Officer and Treasurer | 395.2K | 118.5K | 600.2K | — | — | 12.4K | 1.13M | 53.29% | ↗ |
| 40 | 2018 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | — | 4.00M | — | 1.30M | 12.4K | 5.96M | 67.09% | ↗ |
| 41 | 2018 | Christian Voigtlander, Chief Operating Officer | 420.0K | — | 1.75M | — | 554.0K | 12.4K | 2.74M | 63.96% | ↗ |
| 42 | 2018 | Scott E. Lamb, Treasurer and Chief Financial Officer | 395.2K | — | 750.2K | — | 474.2K | 12.4K | 1.63M | 45.97% | ↗ |
| 43 | 2018 | Scott Lamb, Former Chief Financial Officer and Treasurer | 395.2K | — | 750.2K | — | 474.2K | 12.4K | 1.63M | 45.97% | ↗ |
| 44 | 2018 | Scott E. Lamb, Former Chief Financial Officer and Treasurer | 395.2K | — | 750.2K | — | 474.2K | 12.4K | 1.63M | 45.97% | ↗ |
| 45 | 2018 | Virginia Sanzone, Corporate Vice President, General Counsel | 300.0K | — | 750.2K | — | 410.0K | 12.4K | 1.47M | 50.94% | ↗ |
| 46 | 2018 | Alison D. Burcar, Corporate Vice President, Product Strategy - IV Consumables | 315.0K | — | 500.0K | — | 300.0K | 12.4K | 1.13M | 44.35% | ↗ |
| 47 | 2017 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | — | 1.85M | — | 1.30M | 18.1K | 3.82M | 48.46% | ↗ |
| 48 | 2017 | Scott E. Lamb, Treasurer and Chief Financial Officer | 395.2K | — | 550.3K | — | 474.2K | 9.5K | 1.43M | 38.51% | ↗ |
| 49 | 2017 | Scott E. Lamb, Former Chief Financial Officer and Treasurer | 395.2K | — | 550.3K | — | 474.2K | 9.5K | 1.43M | 38.51% | ↗ |
| 50 | 2017 | Alison D. Burcar, Corporate Vice President, Product Strategy - IV Consumables | 315.0K | — | 475.1K | — | 264.6K | 9.5K | 1.06M | 44.65% | ↗ |
| 51 | 2017 | Alison D. Burcar, Vice President and General Manager of Infusion Systems | 315.0K | — | 475.1K | — | 264.6K | 9.5K | 1.06M | 44.65% | ↗ |
| 52 | 2017 | Steven C. Riggs, Vice President of Operations | 360.6K | — | 425.3K | — | 255.0K | 9.5K | 1.05M | 40.49% | ↗ |
| 53 | 2017 | Tom McCall, Vice President and General Manager of Critical Care | 293.6K | — | 325.3K | — | 352.0K | 9.5K | 980.3K | 33.18% | ↗ |
| 54 | 2016 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | — | 1.95M | — | 942.5K | 9.3K | 3.55M | 54.90% | ↗ |
| 55 | 2016 | Scott E. Lamb, Treasurer and Chief Financial Officer | 395.2K | — | 474.2K | — | 343.8K | 9.3K | 1.22M | 38.79% | ↗ |
| 56 | 2016 | Alison D. Burcar, Corporate Vice President, Product Strategy - IV Consumables | 315.0K | — | 630.0K | — | 260.3K | 9.3K | 1.21M | 51.87% | ↗ |
| 57 | 2016 | Alison D. Burcar, Vice President and General Manager of Infusion Systems | 315.0K | — | 630.0K | — | 260.3K | 9.3K | 1.21M | 51.87% | ↗ |
| 58 | 2016 | Steven C. Riggs, Vice President of Operations | 360.6K | — | 432.9K | — | 313.7K | 9.3K | 1.12M | 38.77% | ↗ |
| 59 | 2016 | Tom McCall, Vice President and General Manager of Critical Care | 293.6K | — | 352.3K | — | 232.4K | 9.1K | 887.3K | 39.70% | ↗ |
| 60 | 2015 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 650.0K | — | 1.46M | 1.46M | 975.0K | 948.00 | 4.55M | 64.27% | ↗ |
| 61 | 2015 | Scott E. Lamb, Treasurer and Chief Financial Officer | 395.2K | — | 395.2K | 395.2K | 355.6K | 9.1K | 1.55M | 50.98% | ↗ |
| 62 | 2015 | Steven C. Riggs, Vice President of Operations | 360.6K | — | 360.6K | 360.6K | 324.5K | 9.1K | 1.42M | 50.95% | ↗ |
| 63 | 2015 | Alison D. Burcar, Vice President and General Manager of Infusion Systems | 315.0K | — | 315.0K | 315.0K | 283.5K | 9.1K | 1.24M | 50.91% | ↗ |
| 64 | 2015 | Tom McCall, Vice President and General Manager of Critical Care | 293.6K | — | 176.2K | 176.2K | 237.8K | 9.1K | 892.8K | 39.47% | ↗ |
| 65 | 2014 | Vivek Jain, Chairman of the Board and Chief Executive Officer | 574.2K | — | 4.00M | 11.90M | 910.0K | — | 17.38M | 91.46% | ↗ |
| 66 | 2014 | Steven C. Riggs, Vice President of Operations | 390.5K | — | — | 2.38M | 328.1K | 9.1K | 3.11M | 76.60% | ↗ |
| 67 | 2014 | Scott E. Lamb, Treasurer and Chief Financial Officer | 395.2K | — | — | 1.91M | 359.6K | 9.1K | 2.67M | 71.39% | ↗ |
| 68 | 2014 | Alison D. Burcar, Vice President and General Manager of Infusion Systems | 315.0K | — | — | 1.43M | 264.6K | 9.6K | 2.02M | 70.81% | ↗ |
| 69 | 2014 | Tom McCall, Vice President and General Manager of Critical Care | 293.6K | 40.0K | — | 70.4K | 143.8K | 8.1K | 555.8K | 12.66% | ↗ |
| 70 | 2014 | Richard A. Costello, Former Vice President of Sales | 123.4K | — | — | — | — | — | 123.4K | 0.00% | ↗ |
| 71 | 2013 | George A. Lopez, M.D., Chairman of the Board, Former President and Chief Executive Officer | 710.8K | — | 350.5K | 1.13M | 207.3K | — | 2.40M | 61.73% | ↗ |
| 72 | 2013 | Steven C. Riggs, Vice President of Operations and Former Acting Chief Executive Officer | 399.4K | — | 104.0K | 489.9K | 61.9K | 8.9K | 1.06M | 55.81% | ↗ |
| 73 | 2013 | Steven C. Riggs, Vice President of Operations | 399.4K | — | 104.0K | 489.9K | 61.9K | 8.9K | 1.06M | 55.81% | ↗ |
| 74 | 2013 | Scott E. Lamb, Treasurer and Chief Financial Officer | 383.6K | 23.0K | 104.0K | 489.9K | 48.3K | 8.9K | 1.06M | 56.15% | ↗ |
| 75 | 2013 | Richard A. Costello, Former Vice President of Sales | 356.5K | — | 104.0K | 489.9K | 37.4K | — | 987.8K | 60.13% | ↗ |
| 76 | 2013 | Alison D. Burcar, Vice President and General Manager of Infusion Systems | 300.0K | 15.0K | 104.0K | 489.9K | 31.5K | 8.9K | 949.4K | 62.56% | ↗ |
| 77 | 2013 | Alison D. Burcar, Vice President of Product Development | 300.0K | 15.0K | 104.0K | 489.9K | 31.5K | 8.9K | 949.4K | 62.56% | ↗ |
| 78 | 2012 | George A. Lopez, M.D., Chairman of the Board, Former President and Chief Executive Officer | 690.1K | — | 366.6K | 1.22M | 891.4K | 15.8K | 3.19M | 49.86% | ↗ |
| 79 | 2012 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 690.1K | — | 366.6K | 1.22M | 891.4K | 15.8K | 3.19M | 49.86% | ↗ |
| 80 | 2012 | Scott E. Lamb, Treasurer and Chief Financial Officer | 372.4K | — | 109.9K | 373.4K | 230.2K | 14.0K | 1.10M | 43.94% | ↗ |
| 81 | 2012 | Steven C. Riggs, Vice President of Operations | 339.9K | — | 95.6K | 324.9K | 175.0K | 15.8K | 951.2K | 44.21% | ↗ |
| 82 | 2012 | Steven C. Riggs, Vice President of Operations and Former Acting Chief Executive Officer | 339.9K | — | 95.6K | 324.9K | 175.0K | 15.8K | 951.2K | 44.21% | ↗ |
| 83 | 2012 | Richard A. Costello, Former Vice President of Sales | 346.1K | — | 64.0K | 217.5K | 160.9K | — | 788.5K | 35.70% | ↗ |
| 84 | 2012 | Richard A. Costello, Vice President of Sales | 346.1K | — | 64.0K | 217.5K | 160.9K | — | 788.5K | 35.70% | ↗ |
| 85 | 2012 | Alison D. Burcar, Vice President of Product Development | 231.8K | — | 43.6K | 148.0K | 119.4K | 9.9K | 552.6K | 34.66% | ↗ |
| 86 | 2012 | Alison D. Burcar, Vice President and General Manager of Infusion Systems | 231.8K | — | 43.6K | 148.0K | 119.4K | 9.9K | 552.6K | 34.66% | ↗ |
| 87 | 2011 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 670.0K | — | — | 1.06M | 1.06M | 1.01M | 3.81M | 27.98% | ↗ |
| 88 | 2011 | George A. Lopez, M.D., Chairman of the Board, Former President and Chief Executive Officer | 670.0K | — | — | 1.06M | 1.06M | 1.01M | 3.81M | 27.98% | ↗ |
| 89 | 2011 | Steven C. Riggs, Vice President of Operations | 330.0K | — | — | 474.3K | 204.6K | 408.9K | 1.42M | 33.45% | ↗ |
| 90 | 2011 | Steven C. Riggs, Vice President of Operations and Former Acting Chief Executive Officer | 330.0K | — | — | 474.3K | 204.6K | 408.9K | 1.42M | 33.45% | ↗ |
| 91 | 2011 | Richard A. Costello, Former Vice President of Sales | 336.0K | — | — | 474.3K | 208.3K | 333.0K | 1.35M | 35.09% | ↗ |
| 92 | 2011 | Richard A. Costello, Vice President of Sales | 336.0K | — | — | 474.3K | 208.3K | 333.0K | 1.35M | 35.09% | ↗ |
| 93 | 2011 | Scott E. Lamb, Treasurer and Chief Financial Officer | 361.6K | — | — | 474.3K | 269.0K | 210.1K | 1.32M | 36.07% | ↗ |
| 94 | 2011 | Alison D. Burcar, Vice President of Product Development | 225.0K | 5.0K | — | 316.2K | 77.0K | 221.6K | 844.8K | 37.43% | ↗ |
| 95 | 2010 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 670.0K | — | — | 849.6K | 1.14M | 33.0K | 2.69M | 31.58% | ↗ |
| 96 | 2010 | George A. Lopez, M.D., Chairman of the Board, President and Chief | 670.0K | — | — | — | 1.14M | 33.0K | 2.69M | 0.00% | ↗ |
| 97 | 2010 | Scott E. Lamb, Treasurer and Chief Financial Officer | 341.0K | 100.0K | — | 318.6K | 204.6K | 7.4K | 971.6K | 32.79% | ↗ |
| 98 | 2010 | Steven C. Riggs, Vice President of Operations | 330.0K | — | — | 318.6K | 165.3K | 11.8K | 825.6K | 38.59% | ↗ |
| 99 | 2010 | Richard A. Costello, Vice President of Sales | 336.0K | — | — | 318.6K | 168.0K | — | 822.6K | 38.73% | ↗ |
| 100 | 2010 | Alison D. Burcar, Vice President of Product Development | 195.0K | 80.0K | — | 62.6K | 58.5K | — | 396.1K | 15.81% | ↗ |
| 101 | 2009 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 544.0K | — | — | — | 704.0K | 8.1K | 2.46M | 0.00% | ↗ |
| 102 | 2009 | George A. Lopez, M.D., Chairman of the Board, President and Chief | 544.0K | — | — | — | 704.0K | 8.1K | 2.46M | 0.00% | ↗ |
| 103 | 2009 | Steven C. Riggs, Vice President of Operations | 280.0K | — | — | — | 120.5K | 7.3K | 808.8K | 0.00% | ↗ |
| 104 | 2009 | Scott E. Lamb, Secretary, Treasurer and Chief Financial Officer | 275.0K | — | — | — | — | — | 803.3K | 0.00% | ↗ |
| 105 | 2009 | Scott E. Lamb, Treasurer and Chief Financial Officer | 275.0K | — | — | — | 118.8K | 8.6K | 803.3K | 0.00% | ↗ |
| 106 | 2009 | Richard A. Costello, Vice President of Sales | 280.0K | — | — | — | 120.5K | — | 801.5K | 0.00% | ↗ |
| 107 | 2009 | Alison D. Burcar, Vice President of Product Development | 195.0K | — | — | — | 58.5K | — | 453.1K | 0.00% | ↗ |
| 108 | 2009 | Alison D. Burcar, Vice President of Marketing | 195.0K | — | — | — | — | — | 453.1K | 0.00% | ↗ |
| 109 | 2008 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 500.0K | — | — | — | — | — | 1.94M | 0.00% | ↗ |
| 110 | 2008 | George A. Lopez, M.D., Chairman of the Board, President and Chief | 500.0K | — | — | — | 590.0K | 2.3K | 1.94M | 0.00% | ↗ |
| 111 | 2008 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 500.0K | — | — | — | 590.0K | 2.3K | 1.40M | 0.00% | ↗ |
| 112 | 2008 | Steven C. Riggs, Vice President of Operations | 260.0K | — | — | — | 91.0K | 8.1K | 630.3K | 0.00% | ↗ |
| 113 | 2008 | Richard A. Costello, Vice President of Sales | 260.0K | 20.0K | — | — | 75.0K | — | 626.3K | 0.00% | ↗ |
| 114 | 2008 | Scott E. Lamb, Secretary, Treasurer and Chief Financial Officer | 204.6K | — | — | — | — | — | 557.4K | 0.00% | ↗ |
| 115 | 2008 | Scott E. Lamb, Treasurer and Chief Financial Officer | 204.6K | — | — | — | 73.5K | 8.1K | 557.4K | 0.00% | ↗ |
| 116 | 2008 | Alison D. Burcar, Vice President of Product Development | 195.0K | — | — | — | 58.5K | — | 524.8K | 0.00% | ↗ |
| 117 | 2008 | Steven C. Riggs, Vice President of Operations | 260.0K | — | — | — | 91.0K | 8.1K | 463.1K | 0.00% | ↗ |
| 118 | 2008 | Scott E. Lamb, Secretary, Treasurer and Chief Financial Officer | 204.6K | — | — | — | 73.5K | 8.1K | 461.3K | 0.00% | ↗ |
| 119 | 2008 | Richard A. Costello, Vice President of Sales | 260.0K | 20.0K | — | — | 75.0K | — | 459.1K | 0.00% | ↗ |
| 120 | 2008 | Alison D. Burcar, Vice President of Marketing | 195.0K | — | — | — | 58.5K | — | 431.3K | 0.00% | ↗ |
| 121 | 2008 | Francis J. O’Brien, former Secretary, Treasurer and Chief Financial Officer | 111.5K | — | — | — | — | 5.4K | 117.0K | 0.00% | ↗ |
| 122 | 2007 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 500.0K | 387.5K | — | — | — | — | 1.99M | 0.00% | ↗ |
| 123 | 2007 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 500.0K | 387.5K | — | — | — | 11.4K | 980.3K | 0.00% | ↗ |
| 124 | 2007 | George A. Lopez, M.D. Chairman of the Board, President and Chief Executive Officer | 500.0K | 375.0K | — | 81.5K | — | 11.4K | 967.8K | 8.42% | ↗ |
| 125 | 2007 | Scott E. Lamb, Secretary, Treasurer and Chief Financial Officer | 180.0K | 27.0K | — | — | — | — | 574.5K | 0.00% | ↗ |
| 126 | 2007 | Francis J. O’Brien, former Secretary, Treasurer and Chief Financial Officer | 300.0K | 67.5K | — | — | — | 9.2K | 506.3K | 0.00% | ↗ |
| 127 | 2007 | Francis J. O’Brien Secretary, Treasurer and Chief Financial Officer | 300.0K | 67.5K | — | 129.6K | — | 9.2K | 506.3K | 25.60% | ↗ |
| 128 | 2007 | Richard A. Costello, Vice President of Sales | 250.0K | 56.3K | — | — | — | 4.3K | 337.7K | 0.00% | ↗ |
| 129 | 2007 | Richard A. Costello Vice President of Sales | 250.0K | 56.3K | — | 27.2K | — | 4.3K | 337.7K | 8.04% | ↗ |
| 130 | 2007 | Steven C. Riggs Vice President of Operations | 231.0K | 52.0K | — | 27.2K | — | 6.1K | 316.2K | 8.59% | ↗ |
| 131 | 2007 | Steven C. Riggs, Vice President of Operations | 231.0K | 52.0K | — | — | — | 6.1K | 316.2K | 0.00% | ↗ |
| 132 | 2007 | Scott E. Lamb, Secretary, Treasurer and Chief Financial Officer | 180.0K | 27.0K | — | — | — | 5.4K | 310.7K | 0.00% | ↗ |
| 133 | 2007 | Alison D. Burcar, Vice President of Marketing | 143.4K | 32.6K | — | — | — | 3.1K | 280.0K | 0.00% | ↗ |
| 134 | 2007 | Scott E. Lamb Controller | 180.0K | 27.0K | — | 27.2K | — | 5.4K | 239.5K | 11.34% | ↗ |
| 135 | 2006 | George A. Lopez, M.D., Chairman of the Board, President and Chief Executive Officer | 500.0K | 625.0K | — | — | — | 329.8K | 1.47M | 0.00% | ↗ |
| 136 | 2006 | George A. Lopez, M.D. Chairman of the Board, President and Chief Executive Officer | 500.0K | 625.0K | — | 12.4K | — | 329.8K | 1.47M | 0.85% | ↗ |
| 137 | 2006 | Steven C. Riggs, Vice President of Operations | 231.0K | 86.6K | — | — | 92.4K | 2.5K | 412.5K | 0.00% | ↗ |
| 138 | 2006 | Steven C. Riggs Vice President of Operations | 231.0K | 86.6K | — | — | 92.4K | 2.1K | 412.1K | 0.00% | ↗ |
| 139 | 2006 | Francis J. O’Brien Secretary, Treasurer and Chief Financial Officer | 290.0K | 108.8K | — | — | — | 5.0K | 404.1K | 0.00% | ↗ |
| 140 | 2006 | Francis J. O’Brien, former Secretary, Treasurer and Chief Financial Officer | 290.0K | 108.8K | — | — | — | 5.3K | 404.1K | 0.00% | ↗ |
| 141 | 2006 | Richard A. Costello, Vice President of Sales | 215.0K | 93.8K | — | — | — | 4.1K | 312.8K | 0.00% | ↗ |
| 142 | 2006 | Richard A. Costello Vice President of Sales | 215.0K | 93.8K | — | — | — | 3.8K | 312.5K | 0.00% | ↗ |
| 143 | 2006 | Scott E. Lamb, Secretary, Treasurer and Chief Financial Officer | 164.0K | 49.8K | — | — | 65.6K | 3.5K | 309.5K | 0.00% | ↗ |
| 144 | 2006 | Scott E. Lamb Controller | 164.0K | 49.8K | — | 26.7K | 65.6K | 3.1K | 309.2K | 8.63% | ↗ |
| 145 | 2006 | Alison D. Burcar, Vice President of Marketing | 133.1K | 50.8K | — | — | — | — | 217.6K | 0.00% | ↗ |
| 146 | 2004 | George A. Lopez Chairman of the Board, President and Chief Executive Officer Secretary, Treasurer and Chief Financial Officer Vice President of Sales Vice President of Operations | 340.0K | — | — | — | — | 62.5K | 402.5K | 0.00% | ↗ |
| 147 | 2003 | George A. Lopez Chairman of the Board, President and Chief Executive Officer Secretary, Treasurer and Chief Financial Officer Vice President of Sales Vice President of Operations | 340.0K | 187.0K | — | — | — | 48.1K | 575.1K | 0.00% | ↗ |
| 148 | 2003 | Alison D. Burcar Vice President of Marketing | 222.0K | 27.8K | — | — | — | 2.4K | 252.2K | 0.00% | ↗ |
| 149 | 2002 | George A. Lopez Chairman of the Board, President and Chief Executive Officer Secretary, Treasurer and Chief Financial Officer Vice President of Sales Vice President of Operations | 340.0K | 374.0K | — | — | — | 44.4K | 758.4K | 0.00% | ↗ |
| 150 | 2002 | Alison D. Burcar Vice President of Marketing | 200.0K | 75.0K | — | — | — | 2.1K | 277.1K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vivek Jain | Chief Executive Officer & Chairman of the Board | 2M | male |
| Christian Voigtlander | Chief Operating Officer | 950.0K | male |
| Brian Michael Bonnell | Chief Financial Officer & Treasurer | 902.5K | male |
| Virginia Ruth Sanzone | Corporate Vice President, General Counsel, Secretary & Compliance Officer | 817.0K | female |
| Daniel Woolson | President | 766.7K | male |
| Olivia Barrall | Vice President of Human Resources | — | — |
| Ben Sousa | Chief Information Officer | — | — |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2015-02-13 | 2015-02-26 | Thom Tillis | NC | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-05-06 | 2025-06-06 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-05-06 | 2025-06-09 | Gilbert Cisneros | CA31 | — | Sale | $1,001 - $15,000 | ↗ |
| 2024-10-31 | 2024-11-07 | Josh Gottheimer | NJ05 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2022-02-14 | 2022-03-18 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-12-23 | 2021-01-11 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-12-21 | 2021-01-07 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-09-25 | 2020-10-14 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-24 | 2020-10-14 | Gilbert Cisneros | CA31 | — | Purchase | $15,001 - $50,000 | ↗ |
| 2020-09-23 | 2020-10-14 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-03-31 | 2020-04-16 | Gilbert Cisneros | CA31 | -- | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ICUI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
